Abundant evidences indicate that CCL17 can perform biological functions through interacting with CCR4 in a series of diseases, including tumor-promoting effects on hepatocellular carcinoma and bladder cancer [17-22]. Here, CCR4 is linked to urinary bladder carcinoma.